Form 4: Ares Management Corp Director Bennett Rosenthal Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Bennett Rosenthal, a director at Ares Management Corp, sold a portion of his Class A Common Stock holdings on November 27, 2024, under a pre-arranged 10b5-1 trading plan.
Summary
- Bennett Rosenthal, a director and Co-Founder & Chairman of PEG at Ares Management Corp, sold shares of Class A Common Stock on November 27, 2024.
- The sales were executed under a pre-arranged 10b5-1 trading plan adopted on August 16, 2024.
- The transactions involved multiple sales at varying prices, with weighted average prices reported for each block of shares sold.
- A total of 29,107 shares were sold directly, and the remaining shares are held indirectly through BAR Holdings, LLC and Ares Owners Holdings L.P.
- The sales prices ranged from $174.65 to $179.78 per share.
Sentiment
Score: 5
Explanation: The document reflects a routine insider sale under a pre-arranged plan, which is neither particularly positive nor negative. It's a neutral event from an investment perspective.
Risks
- Sales by insiders can sometimes be perceived negatively by the market, potentially impacting the stock price.
Industry Context
Insider trading activity is a common occurrence in publicly traded companies, and these transactions are closely monitored by regulators and investors.
Comparison to Industry Standards
- Sales under 10b5-1 plans are a common practice for corporate insiders to diversify their holdings while avoiding accusations of trading on non-public information.
- The reported transactions are consistent with standard SEC reporting requirements for insider sales.
Stakeholder Impact
- The share sales may have a minor impact on the stock price, but the pre-arranged nature of the sales should mitigate any significant negative reaction.
Key Dates
| Date | Description |
|---|---|
| 08/16/2024 | Date the 10b5-1 trading plan was adopted. |
| 11/27/2024 | Date of the share sales. |
| 12/02/2024 | Date the Form 4 was signed. |
Keywords
Ares Management Corp, Bennett Rosenthal, insider trading, Form 4, 10b5-1 plan, Class A Common Stock, share sale, director
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.